Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cytek Biosciences Inc (CTKB)

Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cytek Biosciences Inc 47215 Lakeview Blvd. Fremont CA 94538 USA

https://cytekbio.com Employees: 648 P: 877-922-9835

Sector:

Medical

Description:

Cytek Biosciences Inc provides cell analysis solutions. The company developed high-resolution, high-content and high-sensitivity cell analysis technology called Full Spectrum Profiling. Cytek Biosciences Inc is based in FREMONT, Calif.

Key Statistics

Overview:

Market Capitalization, $K 718,601
Enterprise Value, $K 620,901
Shares Outstanding, K 127,865
Float, K 114,657
% Float 89.67%
Short Interest, K 6,791
Short Float 5.31%
Days to Cover 5.31
Short Volume Ratio 0.50
% of Insider Shareholders 10.33%
% of Institutional Shareholders 69.46%

Financials:

Annual Sales, $ 200,450 K
Annual Net Income, $ -6,020 K
Last Quarter Sales, $ 52,290 K
Last Quarter Net Income, $ -5,480 K
EBIT, $ -31,800 K
EBITDA, $ -21,310 K

Growth:

1-Year Return -1.64%
3-Year Return -48.96%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 11/05/25
Next Earnings Date 02/26/26
Earnings Per Share ttm -0.10
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -500.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CTKB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -3.35%
Return-on-Assets % -2.60%
Profit Margin % -3.00%
Debt/Equity 0.00
Price/Sales 3.65
Price/Cash Flow 160.22
Price/Book 1.87
Book Value/Share 2.98
Interest Coverage -2.09
60-Month Beta 1.30
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar